Ledger.Open graph →
SEC Form D · filed February 6, 2018

Daisy Pharma Opioid Venture, LLC

Offering
$75.0M
Sold
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
SCOTTSDALE, AZ
Type

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (4)

Brent B. Nerguizian · Scottsdale, AZExecKendric B. Speagle · Scottsdale, AZExecBrent B. Nerguizian · Scottsdale, AZExecKendric B. Speagle · Scottsdale, AZExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗